Literature DB >> 24424244

Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress.

Li Fang1, Xiurong Li1, Yuan Luo1, Weichun He1, Chunsun Dai1, Junwei Yang2.   

Abstract

Podocyte apoptosis is a major factor inducing podocyte depletion that predicts the progressive course of glomerulosclerosis. However, the molecular mechanisms underlying podocyte apoptosis are still not well understood. Autophagy is a lysosomal degradation system involving the degradation and recycling of obsolete, damaged, or harmful cytoplasmic materials and organelles. Recent advances in the understanding of the molecular processes contributing to autophagy have provided insight into the relationship between autophagy and apoptosis. However, their cross-talk remains largely obscure until now. Here, we found that podocytes both in vivo and in vitro always exhibited high basal levels of autophagy, whereas autophagy inhibition could induce podocyte apoptosis, suggesting the pro-survival role of autophagy in podocytes. Besides, we found that autophagy inhibition by 3-methyladenine (3-MA) could induce the activation of endoplasmic reticulum stress even without any external stimulations, whereas knockdown of CHOP could effectively improve podocyte apoptosis and down-regulated expression of slit-diaphragm proteins induced by autophagy inhibition. Collectively, this study demonstrated that autophagy might act as a crucial regulatory mechanism of apoptotic cell death by modulating the balance between the pro-survival pathway and the pro-apoptotic pathway of endoplasmic reticulum stress, which might provide a novel mechanistic insight into the interface between autophagy and apoptosis in the progression of podocyte injury.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; Endoplasmic reticulum stress; Podocyte

Mesh:

Substances:

Year:  2014        PMID: 24424244     DOI: 10.1016/j.yexcr.2014.01.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.

Authors:  Mixuan Yi; Lei Zhang; Yu Liu; Man J Livingston; Jian-Kang Chen; N Stanley Nahman; Fuyou Liu; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-12

2.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 3.  Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.

Authors:  Lili Zhou; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

4.  Autophagy modulates endoplasmic reticulum stress-induced cell death in podocytes: a protective role.

Authors:  Yu-Chi Cheng; Jer-Ming Chang; Chien-An Chen; Hung-Chun Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-15

5.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

6.  p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.

Authors:  Danna Zheng; Mei Tao; Xudong Liang; Yiwen Li; Juan Jin; Qiang He
Journal:  Histol Histopathol       Date:  2019-10-25       Impact factor: 2.303

7.  Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.

Authors:  Olivia Lenoir; Magali Jasiek; Carole Hénique; Léa Guyonnet; Björn Hartleben; Tillmann Bork; Anna Chipont; Kathleen Flosseau; Imane Bensaada; Alain Schmitt; Jean-Marc Massé; Michèle Souyri; Tobias B Huber; Pierre-Louis Tharaux
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

8.  Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.

Authors:  Zeng Si Wang; Fei Xiong; Xiao Hang Xie; Dan Chen; Jian Hua Pan; Li Cheng
Journal:  BMC Nephrol       Date:  2015-03-31       Impact factor: 2.388

Review 9.  Oxidative stress and autophagy: crucial modulators of kidney injury.

Authors:  Angara Sureshbabu; Stefan W Ryter; Mary E Choi
Journal:  Redox Biol       Date:  2015-01-13       Impact factor: 11.799

10.  Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.

Authors:  Hengjiang Guo; Yi Wang; Xuemei Zhang; Yingjun Zang; Yang Zhang; Li Wang; Hao Wang; Yunman Wang; Aili Cao; Wen Peng
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.